Oxazoles
Aobchem Cyclobutyl(3-methoxyphenyl)methanone | ≥95% | CAS 898790-44-8 | C12H14O2 | 1g
Cyclobutyl(3-methoxyphenyl)methanone | ≥95% | CAS 898790-44-8 | C12H14O2 | 1g
Aobchem 1-(3-Ethoxy-5-methoxyphenyl)-2 2 2-trifluoroethanone | 95% | C11H11F3O3 | 250mg
1-(3-Ethoxy-5-methoxyphenyl)-2 2 2-trifluoroethanone | 95% | C11H11F3O3 | 250mg
Aobchem (5-Ethyl-2-methoxyphenyl)boronic acid | ≥97% | CAS 847345-37-3 | C9H13BO3 | 5g
(5-Ethyl-2-methoxyphenyl)boronic acid | ≥97% | CAS 847345-37-3 | C9H13BO3 | 5g
Aobchem 1-(2-Bromo-5-methoxyphenyl)ethanol | ≥95% | CAS 71095-23-3 | C9H11BrO2 | 250mg
1-(2-Bromo-5-methoxyphenyl)ethanol | ≥95% | CAS 71095-23-3 | C9H11BrO2 | 250mg
Aobchem 2-(3-Methoxyphenyl)-3-pyridinamine | ≥97% | CAS 886508-13-0 | C12H12N2O | 500mg
2-(3-Methoxyphenyl)-3-pyridinamine | ≥97% | CAS 886508-13-0 | C12H12N2O | 500mg
Aobchem 1-(3-Methoxyphenyl)-2-methylpropan-1-one | ≥97% | CAS 6026-75-1 | C11H14O2 | 1g
1-(3-Methoxyphenyl)-2-methylpropan-1-one | ≥97% | CAS 6026-75-1 | C11H14O2 | 1g
Aobchem 1-(5-Bromo-2-methoxyphenyl)ethanol | ≥95% | CAS 16602-17-8 | C9H11BrO2 | 250mg
1-(5-Bromo-2-methoxyphenyl)ethanol | ≥95% | CAS 16602-17-8 | C9H11BrO2 | 250mg
Aobchem 2-(5-Ethyl-2-methoxyphenyl)-4 4 5 5-tetramethyl-1 3 2-dioxaborolane | ≥97% | CAS 868167-66-2 | C15H23BO3 | 5g
2-(5-Ethyl-2-methoxyphenyl)-4 4 5 5-tetramethyl-1 3 2-dioxaborolane | ≥97% | CAS 868167-66-2 | C15H23BO3 | 5g
Aobchem 3-(3-Methoxyphenyl)-2-propynoic acid | ≥95% | CAS 7621-89-8 | C10H8O3 | 1g
3-(3-Methoxyphenyl)-2-propynoic acid | ≥95% | CAS 7621-89-8 | C10H8O3 | 1g
Aobchem 2-(Oxazol-5-yl)phenol | ≥95% | CAS 391927-03-0 | C9H7NO2 | 10g
2-(Oxazol-5-yl)phenol | ≥95% | CAS 391927-03-0 | C9H7NO2 | 10g
Medchemexpress LLC 4-((R)-1-aminoethyl)-N-(pyridin-4-yl)benzamide | 199433-58-4 | 98.4% | 280.33 | C16H16N4O | 1 ML
Y-33075 is a selective Rho-associated kinase (ROCK) inhibitor derived from Y-27632. It is reported to be more potent than Y-27632, with an IC50 of approximately 3.6 nM, and is used in biochemical and cellular studies to investigate ROCK-dependent signaling.
- Selective ROCK inhibition with low-nanomolar potency (IC50 ≈ 3.6 nM).
- Useful for biochemical and cellular assays probing ROCK signaling.
- High chemical purity (~98.4%) suitable for research use.
- Known chemical identity: 4-((R)-1-aminoethyl)-N-(pyridin-4-yl)benzamide, C16H16N4O.
- Molecular weight 280.33 g/mol.
Aobchem 2-(3-Methoxyphenyl)-3-pyridinamine | ≥97% | CAS 886508-13-0 | C12H12N2O | 1g
2-(3-Methoxyphenyl)-3-pyridinamine | ≥97% | CAS 886508-13-0 | C12H12N2O | 1g
Medchemexpress LLC Dynamin I Antibody (YA4184) | 97 kDa | 100 UL
The Dynamin I Antibody (YA4184) is a mouse-derived, non-conjugated IgG2a monoclonal antibody designed for research applications. It specifically targets human Dynamin I and is suitable for various immunological assays.
- Mouse-derived IgG2a monoclonal antibody
- Targets Dynamin I
- Reacts with human samples
- Predicted and observed molecular weight: 97 kDa
- Affinity purified
- Non-conjugated and unmodified
- Formulated in PBS with 0.05% sodium azide
- Suitable for WB, IHC-P, and ELISA applications
- Store at -20°C for 1 year, avoid repeated freeze/thaw cycles
Medchemexpress LLC Y-320 | 288250-47-5 | 99.0% | 505.01 | 10 MG
Y-320 is a potent, orally active phenylpyrazoleanilide immunomodulator. It inhibits IL-17 production by CD4 T cells stimulated with IL-15 and enhances TP53, DMD, and COL17A1 PTC readthrough by G418. This compound significantly sensitizes multidrug resistance tumors by inducing G2/M phase arrest and apoptosis when used with low-dose Paclitaxel, making it suitable for research on rheumatoid arthritis and cancer.
- Potent, orally active immunomodulator
- Inhibits IL-17 production by CD4 T cells
- Enhances PTC readthrough for TP53, DMD, and COL17A1
- Increases cellular protein levels and synthesis
- Sensitizes multidrug resistance (MDR) tumors
- Induces G2/M phase arrest and apoptosis
- Ameliorates collagen-induced arthritis (CIA)
- Used in research for rheumatoid arthritis and cancer